Kappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors

Allen, 2020, Left and right hemispheric lateralization of the amygdala in pain, Prog. Neurobiol., 101891 Apkarian, 2013, Neural mechanisms of pain and alcohol dependence, Pharmacol. Biochem. Behav., 112C, 34, 10.1016/j.pbb.2013.09.008 Beckerman, 2013, Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis, Exp. Neurol., 239, 120, 10.1016/j.expneurol.2012.10.009 Bruchas, 2010, The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors, Brain Res., 1314, 44, 10.1016/j.brainres.2009.08.062 Bruchas, 2009, CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior, PLoS One, 4, 10.1371/journal.pone.0008528 Cahill, 2014, Does the kappa opioid receptor system contribute to pain aversion?, Front. Pharmacol., 5, 253, 10.3389/fphar.2014.00253 Carrasquillo, 2008, Hemispheric lateralization of a molecular signal for pain modulation in the amygdala, Mol. Pain, 4, 24, 10.1186/1744-8069-4-24 Chieng, 2006, Characterization of neurons in the rat central nucleus of the amygdala: cellular physiology, morphology, and opioid sensitivity, J. Comp. Neurol., 497, 910, 10.1002/cne.21025 Corder, 2019, An amygdalar neural ensemble that encodes the unpleasantness of pain, Science, 363, 276, 10.1126/science.aap8586 Crowley, 2016, Dynorphin controls the gain of an amygdalar anxiety circuit, Cell Rep., 14, 2774, 10.1016/j.celrep.2016.02.069 De Guglielmo, 2019, Inactivation of a CRF-dependent amygdalofugal pathway reverses addiction-like behaviors in alcohol-dependent rats, Nat. Commun., 10, 1238, 10.1038/s41467-019-09183-0 Fendt, 1997, Corticotropin-releasing factor in the caudal pontine reticular nucleus mediates the expression of fear-potentiated startle in the rat, Eur. J. Neurosci., 9, 299, 10.1111/j.1460-9568.1997.tb01400.x Fu, 2008, PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior, Mol. Pain, 4, 26, 10.1186/1744-8069-4-26 Fu, 2008, Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior, J. Neurosci., 28, 3861, 10.1523/JNEUROSCI.0227-08.2008 Gilpin, 2014, Kappa opioid receptor activation decreases inhibitory transmission and antagonizes alcohol effects in rat central amygdala, Neuropharmacology, 77, 294, 10.1016/j.neuropharm.2013.10.005 Goncalves, 2012, Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation, Eur. J. Neurosci., 36, 3204, 10.1111/j.1460-9568.2012.08235.x Han, 2005, Computerized analysis of audible and ultrasonic vocalizations of rats as a standardized measure of pain-related behavior, J. Neurosci. Methods, 141, 261, 10.1016/j.jneumeth.2004.07.005 Harrigan, 1994, Corticotropin releasing factor neurons are innervated by calcitonin gene-related peptide terminals in the rat central amygdaloid nucleus, Brain Res. Bull., 33, 529, 10.1016/0361-9230(94)90079-5 Ikeda, 2007, NMDA receptor-independent synaptic plasticity in the central amygdala in the rat model of neuropathic pain, Pain, 127, 161, 10.1016/j.pain.2006.09.003 Ji, 2015, Reactive oxygen species mediate visceral pain-related amygdala plasticity and behaviors, Pain, 156, 825, 10.1097/j.pain.0000000000000120 Ji, 2009, Hemispheric lateralization of pain processing by amygdala neurons, J. Neurophysiol., 1102, 2253, 10.1152/jn.00166.2009 Ji, 2018, Fear extinction learning ability predicts neuropathic pain behaviors and amygdala activity in male rats, Mol. Pain, 14, 10.1177/1744806918804441 Kang-Park, 2013, kappa-Opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic sites, J. Pharmacol. Exp. Therapeut., 346, 130, 10.1124/jpet.112.202903 Kang-Park, 2015, Interaction of CRF and kappa opioid systems on GABAergic neurotransmission in the mouse central amygdala, J. Pharmacol. Exp. Therapeut., 355, 206, 10.1124/jpet.115.225870 Kim, 2017, Monomethyl fumarate inhibits pain behaviors and amygdala activity in a rat arthritis model, Pain, 158, 2376, 10.1097/j.pain.0000000000001042 King, 2009, Unmasking the tonic-aversive state in neuropathic pain, Nat. Neurosci., 12, 1364, 10.1038/nn.2407 Kiritoshi, 2016, Rescue of impaired mGluR5-driven endocannabinoid signaling restores prefrontal cortical output to inhibit pain in arthritic rats, J. Neurosci., 36, 837, 10.1523/JNEUROSCI.4047-15.2016 Kiritoshi, 2015, Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex, Neuropharmacology, 95, 388, 10.1016/j.neuropharm.2015.04.003 Kiritoshi, 2018, Pathway-specific alterations of cortico-amygdala transmission in an arthritis pain model, ACS Chem. Neurosci., 9, 2252, 10.1021/acschemneuro.8b00022 Kiritoshi, 2013, Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1, Neuropharmacology, 66, 170, 10.1016/j.neuropharm.2012.03.024 Kissiwaa, 2020, Opioids differentially modulate two synapses important for pain processing in the amygdala, Br. J. Pharmacol., 177, 420, 10.1111/bph.14877 Kolber, 2010, Activation of metabotropic glutamate receptor 5 in the amygdala modulates pain-like behavior, J. Neurosci., 30, 8203, 10.1523/JNEUROSCI.1216-10.2010 Koob, 2019, Addiction and stress: an allostatic view, Neurosci. Biobehav. Rev., 106, 245, 10.1016/j.neubiorev.2018.09.008 Lalanne, 2014, The kappa opioid receptor: from addiction to depression, and back, Front. Psychiatr., 5, 170, 10.3389/fpsyt.2014.00170 Land, 2008, The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system, J. Neurosci., 28, 407, 10.1523/JNEUROSCI.4458-07.2008 Le Merrer, 2009, Reward processing by the opioid system in the brain, Physiol. Rev., 89, 1379, 10.1152/physrev.00005.2009 Li, 2011, Mitochondrial reactive oxygen species are activated by mGluR5 through IP3 and activate ERK and PKA to increase excitability of amygdala neurons and pain behavior, J. Neurosci., 31, 1114, 10.1523/JNEUROSCI.5387-10.2011 Liu, 2019, Kappa opioid receptors drive a tonic aversive component of chronic pain, J. Neurosci., 39, 4162, 10.1523/JNEUROSCI.0274-19.2019 Mansour, 1996, Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary, Neuroscience, 71, 671, 10.1016/0306-4522(95)00464-5 Mansour, 1995, Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications, TINS (Trends Neurosci.), 18, 22, 10.1016/0166-2236(95)93946-U Marchant, 2007, Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division, J. Comp. Neurol., 504, 702, 10.1002/cne.21464 Marcilhac, 1997, Identification of projections from the central nucleus of the amygdala to the paraventricular nucleus of the hypothalamus which are immunoreactive for corticotrophin-releasing hormone in the rat, Exp. Physiol., 82, 273, 10.1113/expphysiol.1997.sp004022 Mazzitelli, 2019, Amygdala group II mGluRs mediate the inhibitory effects of systemic group II mGluR activation on behavior and spinal neurons in a rat model of arthritis pain, Neuropharmacology, 158, 107706, 10.1016/j.neuropharm.2019.107706 McCall, 2015, CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety, Neuron, 87, 605, 10.1016/j.neuron.2015.07.002 Nakao, 2012, Role of capsaicin-sensitive C-fiber afferents in neuropathic pain-induced synaptic potentiation in the nociceptive amygdala, Mol. Pain, 8, 51, 10.1186/1744-8069-8-51 Nation, 2018, Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain, Pain, 159, 919, 10.1097/j.pain.0000000000001167 Navratilova, 2019, Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain, Pain, 160, 824, 10.1097/j.pain.0000000000001458 Navratilova, 2020, Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex, Pain, 161, 609, 10.1097/j.pain.0000000000001748 Neugebauer, 2020, Amygdala physiology in pain, Handb. Behav. Neurobiol., 26, 101, 10.1016/B978-0-12-815134-1.00004-0 Neugebauer, 2007, Techniques for assessing knee joint pain in arthritis, Mol. Pain, 3, 8, 10.1186/1744-8069-3-8 Neugebauer, 2003, Synaptic plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5, J. Neurosci., 23, 52, 10.1523/JNEUROSCI.23-01-00052.2003 Neugebauer, 2004, The amygdala and persistent pain, Neuroscientist, 10, 221, 10.1177/1073858403261077 Paxinos, 1998 Phelps, 2019, Kappa opioid signaling in the right central amygdala causes hind paw specific loss of diffuse noxious inhibitory controls in experimental neuropathic pain, Pain, 160, 1614, 10.1097/j.pain.0000000000001553 Phelps, 2005, Contributions of the amygdala to emotion processing: from animal models to human behavior, Neuron, 48, 175, 10.1016/j.neuron.2005.09.025 Pomrenze, 2019, Dissecting the roles of GABA and neuropeptides from rat central amygdala CRF neurons in anxiety and fear learning, Cell Rep., 29, 13, 10.1016/j.celrep.2019.08.083 Pomrenze, 2015, A transgenic rat for investigating the anatomy and function of corticotrophin releasing factor circuits, Front. Neurosci., 9, 487, 10.3389/fnins.2015.00487 Ren, 2013, Neuropeptide S: a novel regulator of pain-related amygdala plasticity and behaviors, J. Neurophysiol., 110, 1765, 10.1152/jn.00874.2012 Reyes, 2011, Amygdalar peptidergic circuits regulating noradrenergic locus coeruleus neurons: linking limbic and arousal centers, Exp. Neurol., 230, 96, 10.1016/j.expneurol.2011.04.001 Sarhan, 2005, Branching patterns of parabrachial neurons projecting to the central extended amgydala: single axonal reconstructions, J. Comp. Neurol., 491, 418, 10.1002/cne.20697 Schwaber, 1988, Neurons containing calcitonin gene-related peptide in the parabrachial nucleus project to the central nucleus of the amygdala, J. Comp. Neurol., 270, 416, 10.1002/cne.902700310 Smith, 2012, Stress-induced activation of the dynorphin/kappa-opioid receptor system in the amygdala potentiates nicotine conditioned place preference, J. Neurosci., 32, 1488, 10.1523/JNEUROSCI.2980-11.2012 Standifer, 1997, G proteins and opioid receptor-mediated signalling, Cell. Signal., 9, 237, 10.1016/S0898-6568(96)00174-X Sugimura, 2016, Synaptic and network consequences of monosynaptic nociceptive inputs of parabrachial nucleus origin in the central amygdala, J. Neurophysiol., 2721, 10.1152/jn.00946.2015 Tejeda, 2017, Pathway- and cell-specific kappa-opioid receptor modulation of excitation-inhibition balance differentially gates D1 and D2 accumbens neuron activity, Neuron, 93, 147, 10.1016/j.neuron.2016.12.005 Thompson, 2015, Small-conductance calcium-activated potassium (SK) channels in the amygdala mediate pain-inhibiting effects of clinically available riluzole in a rat model of arthritis pain, Mol. Pain, 11, 51, 10.1186/s12990-015-0055-9 Thompson, 2019, Cortico-limbic pain mechanisms, Neurosci. Lett., 702, 15, 10.1016/j.neulet.2018.11.037 Thompson, 2018, Small conductance calcium activated potassium (SK) channel dependent and independent effects of riluzole on neuropathic pain-related amygdala activity and behaviors in rats, Neuropharmacology, 138, 219, 10.1016/j.neuropharm.2018.06.015 Watabe, 2013, Synaptic potentiation in the nociceptive amygdala following fear learning in mice, Mol. Brain, 6, 11, 10.1186/1756-6606-6-11 Wilson, 2019, Dual and opposing functions of the central amygdala in the modulation of pain, Cell Rep., 29, 332, 10.1016/j.celrep.2019.09.011 Xie, 2017, Kappa opioid receptor antagonists: a possible new class of therapeutics for migraine prevention, Cephalalgia, 37, 780, 10.1177/0333102417702120 Zhou, 2013, Development of functionally selective, small molecule agonists at kappa opioid receptors, J. Biol. Chem., 288, 36703, 10.1074/jbc.M113.504381 Zhu, 2004, Synaptic properties and postsynaptic opioid effects in rat central amygdala neurons, Neuroscience, 127, 871, 10.1016/j.neuroscience.2004.05.043